BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17626629)

  • 1. Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice.
    Hinkle RT; Lefever FR; Dolan ET; Reichart DL; Dietrich JA; Gropp KE; Thacker RI; Demuth JP; Stevens PJ; Qu XA; Varbanov AR; Wang F; Isfort RJ
    BMC Med; 2007 Jul; 5():18. PubMed ID: 17626629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
    Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S
    Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dystrophin expression and pathology of diaphragm muscles of mdx mice after xenogenic bone marrow stem cell transplantation].
    Zhang YN; Zhang C; Yu MJ; Wang SH; Li MS; Huang H; Xiong F; Feng SW; Liu TY; Lu XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):53-8. PubMed ID: 16495176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.
    Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U
    Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
    Gutpell KM; Hrinivich WT; Hoffman LM
    PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
    Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy.
    Desguerre I; Arnold L; Vignaud A; Cuvellier S; Yacoub-Youssef H; Gherardi RK; Chelly J; Chretien F; Mounier R; Ferry A; Chazaud B
    Muscle Nerve; 2012 Jun; 45(6):803-14. PubMed ID: 22581532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a CRF2R agonist and exercise on mdx and wildtype skeletal muscle.
    Hall JE; Kaczor JJ; Hettinga BP; Isfort RJ; Tarnopolsky MA
    Muscle Nerve; 2007 Sep; 36(3):336-41. PubMed ID: 17503504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
    D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
    Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.
    Bellissimo CA; Gandhi S; Castellani LN; Murugathasan M; Delfinis LJ; Thuhan A; Garibotti MC; Seo Y; Rebalka IA; Hsu HH; Sweeney G; Hawke TJ; Abdul-Sater AA; Perry CGR
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1011-C1026. PubMed ID: 38145301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
    Smith J; Goldsmith C; Ward A; LeDieu R
    Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients.
    Nakayama Y; Nara N; Kawakita Y; Takeshima Y; Arakawa M; Katoh M; Morita S; Iwatsuki K; Tanaka K; Okamoto S; Kitamura T; Seki N; Matsuda R; Matsuo M; Saito K; Hara T
    Am J Pathol; 2004 May; 164(5):1773-82. PubMed ID: 15111323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
    Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
    J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.
    Hnia K; Hugon G; Rivier F; Masmoudi A; Mercier J; Mornet D
    Am J Pathol; 2007 Feb; 170(2):633-43. PubMed ID: 17255331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
    Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
    Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-dystrophin gene transfer in mdx4cv diaphragm muscle fibers increases sarcolemmal stability.
    Decrouy A; Renaud JM; Davis HL; Lunde JA; Dickson G; Jasmin BJ
    Gene Ther; 1997 May; 4(5):401-8. PubMed ID: 9274716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.